China Resources Shuanghe announced that the company and some of its subsidiaries participated in the 12th batch of centralized procurement of national drugs. Amlodipine benazepril capsules, paliperidone sustained-release tablets, vitamin B6 injections, doxazosin mesylate sustained-release tablets, sacubatrivalsartan tablets, perindopril amlodipine tablets, and bunanserin tablets will be selected. The procurement cycle starts from the date of implementation of the selection results until December 31, 2029.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.